A Bilateral Approach To Patient Protection

Traditional offloading devices create a limb length inequality that may cause asymmetrical gait, increased peak plantar pressures, postural instability and a greater risk of falling. [24], [27]

The footwear component of PulseFlowDF is supplied as a pair, with the offloader and intermittent plantar compression (IPC) mechanism fitted to the left or right shoe depending on the location of the ulceration to be treated.

Balance is optimised, the risk of trips and falls due to non-paired footwear is reduced and any patient stigma associated with treatment is reduced as both feet look the same.

D3O® Inside

All PulseFlowDF footwear insoles contain D3O®, designed to encourage a natural and dynamic transition from heel to forefoot. The shock absorbing heel insert reduces the risk of lower limb injuries while impact protection is enhanced by correcting:

  • Impact pressure distribution
  • Dynamic pressure attenuation
  • Acceleration control
  • Stability of the mid-foot

D3O® Comparative Impact Test

D3O® Lite has been engineered to transmit significantly less force compared to standard EVA and other high density foams used in medical footwear, thus reducing the risk of injury to the foot.

D3O® Working Together

D3O® materials in their raw state flow freely when moved slowly, but on shock, lock together to absorb and disperse energy, before instantly returning to their flexible state.

The greater the force of the impact, the more the molecules lock together and the greater the protection.

Ongoing Protection After Treatment

At the end of treatment the offloader and IPC mechanism is removed and the footwear retained by the patient giving ongoing protection and promotion of a healthy in-shoe environment.